ABIGAIL HASKELL: Open Payments
NPI 1215513437 · TRUCKEE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 24 payments from 10 companies in 2025. Trend: 2023 $24 · 2024 $404 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $115 |
| Novartis Pharmaceuticals Corporation | 5 | $112 |
| Axsome Therapeutics, Inc. | 4 | $86 |
| PFIZER INC. | 2 | $44 |
| Indivior Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Braeburn Inc. | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| United Therapeutics Corporation | 1 | $16 |
Products named: Wegovy, LEQVIO, Auvelity, SUBLOCADE, BEXSERO, BRIXADI, AMVUTTRA, ENTRESTO.
Industry payments across CA — which companies pay providers there.
